| 10.1136/rmdopen-2024-004910 |
39.710.430 |
|
Different disease activity trajectories in early axial spondyloarthritis lead to significantly different long-term outcomes: a trajectory-based analysis of the DESIR cohort over 10 years. |
RMD Open |
2024 |
10 |
|
| 10.1017/S0266462324000552 |
39.651.580 |
|
How do we respond to the threat of multidrug-resistant bacteria? Comparison of antibiotic appraisals from 2016 to 2020 of the French, English, and German HTA agencies. |
Int J Technol Assess Health Care |
2024 |
40 |
e72 |
| 10.1002/14651858.CD003218.pub3 |
39.555.632 |
|
Psychostimulants for hypersomnia (excessive daytime sleepiness) in myotonic dystrophy. |
Cochrane Database Syst Rev |
2024 |
11 |
CD003218 |
| 10.1056/EVIDoa2300354 |
39.437.137 |
|
Infliximab versus Cyclophosphamide for Severe Behçet''s Syndrome. |
NEJM Evid |
2024 |
3 |
EVIDoa2300354 |
| 10.1093/jac/dkae350 |
39.327.031 |
|
Outcomes of patients hospitalized in ward settings for COVID-19 pneumonia with or without early empirical antibiotics. |
J Antimicrob Chemother |
2024 |
79 |
3243-3247 |
| 10.1080/19466315.2024.2344543 |
39.301.054 |
|
Bayesian Optimal Designs for Multi-Arm Multi-Stage Phase II Randomized Clinical Trials with Multiple Endpoints. |
Stat Biopharm Res |
2024 |
16 |
315-325 |
| 10.1007/s00520-024-08817-4 |
39.269.541 |
|
Prevalence and risks of intravenous chemotherapy-induced severe neutropenia in solid cancers: a multicenter retrospective cohort study on real-life data. |
Support Care Cancer |
2024 |
32 |
657 |
| 10.1038/s41375-024-02402-8 |
39.266.637 |
|
Eltrombopag in chronic myelomonocytic leukemia with severe thrombocytopenia. A Groupe Francophone des Myélodysplasies (GFM) study. |
Leukemia |
2024 |
38 |
2510-2513 |
| 10.1093/ofid/ofae426 |
39.183.813 |
|
Epidemiology, Clinical Manifestations, Treatment, and Outcome of Mucormycosis: A Review of 77 Cases From a Single Center in France. |
Open Forum Infect Dis |
2024 |
11 |
ofae426 |
| 10.1111/bjh.19691 |
39.159.950 |
|
Long-term outcome after allogeneic stem cell transplantation for GATA2 deficiency: An analysis of 67 adults and children from France and Belgium. |
Br J Haematol |
2024 |
|
|
| 10.1186/s12874-024-02278-3 |
39.030.498 |
|
Bayesian sequential monitoring strategies for trials of digestive cancer therapeutics. |
BMC Med Res Methodol |
2024 |
24 |
154 |
| 10.1136/bjo-2024-325163 |
39.013.629 |
|
Methotrexate versus conventional disease-modifying antirheumatic drugs in the treatment of non-anterior sarcoidosis-associated uveitis. |
Br J Ophthalmol |
2024 |
109 |
34-40 |
| 10.1016/j.eclinm.2024.102679 |
39.007.062 |
|
Real-life efficacy of immunotherapy for Sézary syndrome: a multicenter observational cohort study. |
EClinicalMedicine |
2024 |
73 |
102679 |
| 10.1093/ofid/ofae340 |
38.957.692 |
|
New Insights Into the Therapeutic Management of Varicella Zoster Virus Meningitis: A Series of 123 Polymerase Chain Reaction-Confirmed Cases. |
Open Forum Infect Dis |
2024 |
11 |
ofae340 |
| 10.1093/cid/ciae337 |
38.916.974 |
|
Risk Factors and Outcome Associated With Fungal Infections in Patients With Severe Burn Injury: 10-year Retrospective IFI-BURN Study. |
Clin Infect Dis |
2024 |
79 |
682-689 |
| 10.1016/S1470-2045(24)00282-1 |
38.889.735 |
|
Bortezomib, thalidomide, and dexamethasone with or without daratumumab and followed by daratumumab maintenance or observation in transplant-eligible newly diagnosed multiple myeloma: long-term follow-up of the CASSIOPEIA randomised controlled phase 3 trial. |
Lancet Oncol |
2024 |
25 |
1003-1014 |
| 10.1038/s41408-024-01078-8 |
38.871.702 |
|
Multi-target measurable residual disease assessed by error-corrected sequencing in patients with acute myeloid leukemia: An ALFA study. |
Blood Cancer J |
2024 |
14 |
97 |
| 10.1016/j.jcv.2024.105690 |
38.852.538 |
|
Prospective comparison of cytomegalovirus quantification in whole blood and plasma samples among hematopoietic stem cell transplant and kidney transplant recipients. |
J Clin Virol |
2024 |
174 |
105690 |
| 10.1182/blood.2023023754 |
38.848.537 |
|
NGS-based stratification refines the risk stratification in T-ALL and identifies a very-high-risk subgroup of patients. |
Blood |
2024 |
144 |
1570-1580 |
| 10.1002/sim.10130 |
38.844.988 |
|
Two-stage randomized clinical trials with a right-censored endpoint: Comparison of frequentist and Bayesian adaptive designs. |
Stat Med |
2024 |
43 |
3364-3382 |
| 10.1038/s41591-024-03050-2 |
38.830.994 |
|
Isatuximab, lenalidomide, dexamethasone and bortezomib in transplant-ineligible multiple myeloma: the randomized phase 3 BENEFIT trial. |
Nat Med |
2024 |
30 |
2235-2241 |
| 10.1097/QAD.0000000000003887 |
38.814.715 |
|
Low cabotegravir trough concentrations without oral lead-in in patients with HIV-1 switching to long-acting cabotegravir and rilpivirine. |
AIDS |
2024 |
38 |
1267-1269 |
| 10.1111/bjh.19505 |
38.747.092 |
|
French early nationwide idecabtagene vicleucel chimeric antigen receptor T-cell therapy experience in patients with relapsed/refractory multiple myeloma (FENIX): A real-world IFM study from the DESCAR-T registry. |
Br J Haematol |
2024 |
205 |
990-998 |
| 10.1016/j.ijmedinf.2024.105462 |
38.733.641 |
|
Combining deep neural networks, a rule-based expert system and targeted manual coding for ICD-10 coding causes of death of French death certificates from 2018 to 2019. |
Int J Med Inform |
2024 |
188 |
105462 |
| 10.1186/s12979-024-00430-7 |
38.715.114 |
|
Increased levels of GM-CSF and CXCL10 and low CD8 + memory stem T Cell count are markers of immunosenescence and severe COVID-19 in older people. |
Immun Ageing |
2024 |
21 |
28 |
| 10.1136/bmjopen-2023-081314 |
38.688.666 |
|
Air leak test in the Paediatric Intensive Care Unit (ALTIPICU): rationale and protocol for a prospective multicentre observational study. |
BMJ Open |
2024 |
14 |
e081314 |
| 10.1016/j.ejca.2024.114047 |
38.653.034 |
|
Composite event-free-survival as an endpoint in oncology drug evaluation: Review and guidance perspectives from the Haute Autorité de Santé (HAS). |
Eur J Cancer |
2024 |
204 |
114047 |
| 10.1182/blood.2023022269 |
38.603.637 |
|
What clinicians should know about surrogate end points in hematologic malignancies. |
Blood |
2024 |
144 |
11-20 |
| 10.1177/17407745231221152 |
38.591.582 |
|
Dose optimization for cancer treatments with considerations for late-onset toxicities. |
Clin Trials |
2024 |
21 |
322-330 |
| 10.1007/s00134-024-07390-y |
38.573.403 |
|
A randomised controlled trial of a nurse facilitator to promote communication for family members of critically ill patients. |
Intensive Care Med |
2024 |
50 |
712-724 |
| 10.1038/s41409-024-02268-5 |
38.514.813 |
|
Transplantation for myelofibrosis patients in the ruxolitinib era: a registry study from the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire. |
Bone Marrow Transplant |
2024 |
59 |
965-973 |
| 10.1016/j.cct.2024.107506 |
38.508.234 |
|
Single-arm phase 3 designs: An oxymoron? |
Contemp Clin Trials |
2024 |
141 |
107506 |
| 10.1182/blood.2023023502 |
38.452.207 |
|
Nilotinib with or without cytarabine for Philadelphia-positive acute lymphoblastic leukemia. |
Blood |
2024 |
143 |
2363-2372 |
| 10.1111/ijlh.14257 |
38.439.664 |
|
White blood cells scattergram as a valuable tool for COVID-19 screening: A multicentric study. |
Int J Lab Hematol |
2024 |
46 |
613-619 |
| 10.1111/1471-0528.17794 |
38.425.020 |
|
Vaginal misoprostol versus vaginal dinoprostone for cervical ripening and induction of labour: An individual participant data meta-analysis of randomised controlled trials. |
BJOG |
2024 |
131 |
1167-1180 |
| 10.3324/haematol.2023.284103 |
38.385.260 |
|
A predictive classifier of poor prognosis in transplanted patients with juvenile myelomonocytic leukemia: a study on behalf of the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire. |
Haematologica |
2024 |
109 |
2908-2919 |
| 10.3899/jrheum.2023-0933 |
38.359.943 |
|
Factors Associated With Treatment Pathways in Early Axial Spondyloarthritis: A Multistate Analysis of the 10-Year Follow-Up of the DESIR Cohort. |
J Rheumatol |
2024 |
51 |
368-377 |
| 10.1016/j.therap.2023.12.004 |
38.320.894 |
|
[Chronology of the ISO 9001:2015 certification and satisfaction survey in the multidisciplinary Clinical Investigation Center (CIC) of the historic Saint-Louis Hospital during the COVID-19 pandemic]. |
Therapie |
2024 |
79 |
519-531 |
| 10.1093/bjd/ljae032 |
38.270.968 |
|
Effectiveness and safety of major systemic treatments in classic and endemic Kaposi sarcoma: a multicentre retrospective study of 110 patients. |
Br J Dermatol |
2024 |
190 |
771-773 |
| 10.3201/eid3002.231221 |
38.270.146 |
|
Multicenter Retrospective Study of Invasive Fusariosis in Intensive Care Units, France. |
Emerg Infect Dis |
2024 |
30 |
215-24 |
| 10.1007/s12024-023-00707-1 |
38.085.425 |
|
The last jump: epidemiology of suicides at the Tour Eiffel (Paris) between 1950 and 1989. |
Forensic Sci Med Pathol |
2024 |
20 |
360-369 |
| 10.1002/bimj.202200332 |
37.984.849 |
|
Drug combinations screening using a Bayesian ranking approach based on dose-response models. |
Biom J |
2024 |
66 |
e2200332 |
| 10.1093/postmj/qgad104 |
37.978.265 |
|
Risk factors for thromboembolic events in patients hospitalized for COVID-19 pneumonia in a general ward and requiring treatment with oxygen. |
Postgrad Med J |
2024 |
100 |
120-126 |
| 10.1111/bjh.19163 |
37.953.476 |
|
Low non-relapse mortality and good haematological and renal responses after autologous haematopoietic stem cell transplantation in multiple myeloma patients with renal insufficiency at transplant: A prospective Société Francophone de Greffe de Moelle-Thérapie Cellulaire observational study. |
Br J Haematol |
2024 |
204 |
1450-1458 |
| 10.1182/blood.2023020984 |
37.801.707 |
|
Early complete response as a validated surrogate marker in extranodal marginal zone lymphoma systemic therapy. |
Blood |
2024 |
143 |
422-428 |
| 10.1097/HEP.0000000000000615 |
37.774.387 |
|
The clinical and financial burden of nonhepatocellular carcinoma focal lesions detected during the surveillance of patients with cirrhosis. |
Hepatology |
2024 |
79 |
813-828 |
| 10.1007/s12028-023-01758-6 |
37.286.846 |
|
Clinician-Reported Physical and Cognitive Impairments After Convulsive Status Epilepticus: Post Hoc Study of a Randomized Controlled Trial. |
Neurocrit Care |
2024 |
40 |
495-505 |
| 10.1136/bmjebm-2022-112091 |
36.788.020 |
|
Rapid access to innovative medicinal products while ensuring relevant health technology assessment. Position of the French National Authority for Health. |
BMJ Evid Based Med |
2024 |
29 |
1-5 |
| 10.1080/02688697.2022.2159925 |
36.576.058 |
|
Relative survival after meningioma surgery. A French nationwide population-based cohort study. |
Br J Neurosurg |
2024 |
38 |
1345-1351 |
